Plutux
$0.88
-3.16%
2026-09-02 16:00:00 EDT-$0.03
Healthcare
Biotechnology
NASDAQ
Active Trading

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
CytoMed Therapeutics Limited (GDTC) leadership team and executives